Intravesical Bacillus Calmette-Guérin Versus Combination of Epirubicin and Interferon-?2a in Reducing Recurrence of Non-Muscle-invasive Bladder Carcinoma : FinnBladder-6 Study

Timo Marttila; Riikka Järvinen; Tapani Liukkonen; Erkki Rintala; Peter Boström; Marjo Seppänen; Teuvo Tammela; Pekka Hellström; Sirpa Aaltomaa; Markku Leskinen; Mika Raitanen; Eero Kaasinen

doi:10.1016/j.eururo.2016.03.034

Intravesical Bacillus Calmette-Guérin Versus Combination of Epirubicin and Interferon-?2a in Reducing Recurrence of Non-Muscle-invasive Bladder Carcinoma : FinnBladder-6 Study

Timo Marttila, Riikka Järvinen, Tapani Liukkonen, Erkki Rintala, Peter Boström, Marjo Seppänen, Teuvo Tammela, Pekka Hellström, Sirpa Aaltomaa, Markku Leskinen, Mika Raitanen, Eero Kaasinen

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Pages (from-to)	341-347
Journal	European Urology
Volume	70
Issue number	2
DOIs	https://doi.org/10.1016/j.eururo.2016.03.034
Publication status	Published - 2016
Publication type	A1 Journal article-refereed

Keywords

Bacillus Calmette-Guérin
Epirubicin
Instillation therapy
Interferon ?-2b
Mitomycin C
Recurrent non-muscle-invasive bladder cancer
SWOG

Publication forum classification

Publication forum level 3

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.eururo.2016.03.034

Cite this

Marttila, T., Järvinen, R., Liukkonen, T., Rintala, E., Boström, P., Seppänen, M., Tammela, T., Hellström, P., Aaltomaa, S., Leskinen, M., Raitanen, M., & Kaasinen, E. (2016). Intravesical Bacillus Calmette-Guérin Versus Combination of Epirubicin and Interferon-?2a in Reducing Recurrence of Non-Muscle-invasive Bladder Carcinoma : FinnBladder-6 Study. European Urology, 70(2), 341-347. https://doi.org/10.1016/j.eururo.2016.03.034

@article{df15c163e34a466e880988b91ed485ad,

title = "Intravesical Bacillus Calmette-Gu{\'e}rin Versus Combination of Epirubicin and Interferon-?2a in Reducing Recurrence of Non-Muscle-invasive Bladder Carcinoma : FinnBladder-6 Study",

keywords = "Bacillus Calmette-Gu{\'e}rin, Epirubicin, Instillation therapy, Interferon ?-2b, Mitomycin C, Recurrent non-muscle-invasive bladder cancer, SWOG, Bacillus Calmette-Gu{\'e}rin, Epirubicin, Instillation therapy, Interferon ?-2b, Mitomycin C, Recurrent non-muscle-invasive bladder cancer, SWOG",

author = "Timo Marttila and Riikka J{\"a}rvinen and Tapani Liukkonen and Erkki Rintala and Peter Bostr{\"o}m and Marjo Sepp{\"a}nen and Teuvo Tammela and Pekka Hellstr{\"o}m and Sirpa Aaltomaa and Markku Leskinen and Mika Raitanen and Eero Kaasinen",

year = "2016",

doi = "10.1016/j.eururo.2016.03.034",

language = "English",

volume = "70",

pages = "341--347",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "2",

}

Marttila, T, Järvinen, R, Liukkonen, T, Rintala, E, Boström, P, Seppänen, M, Tammela, T, Hellström, P, Aaltomaa, S, Leskinen, M, Raitanen, M & Kaasinen, E 2016, 'Intravesical Bacillus Calmette-Guérin Versus Combination of Epirubicin and Interferon-?2a in Reducing Recurrence of Non-Muscle-invasive Bladder Carcinoma : FinnBladder-6 Study', European Urology, vol. 70, no. 2, pp. 341-347. https://doi.org/10.1016/j.eururo.2016.03.034

Intravesical Bacillus Calmette-Guérin Versus Combination of Epirubicin and Interferon-?2a in Reducing Recurrence of Non-Muscle-invasive Bladder Carcinoma : FinnBladder-6 Study. / Marttila, Timo; Järvinen, Riikka; Liukkonen, Tapani et al.

In: European Urology, Vol. 70, No. 2, 2016, p. 341-347.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Intravesical Bacillus Calmette-Guérin Versus Combination of Epirubicin and Interferon-?2a in Reducing Recurrence of Non-Muscle-invasive Bladder Carcinoma : FinnBladder-6 Study

AU - Marttila, Timo

AU - Järvinen, Riikka

AU - Liukkonen, Tapani

AU - Rintala, Erkki

AU - Boström, Peter

AU - Seppänen, Marjo

AU - Tammela, Teuvo

AU - Hellström, Pekka

AU - Aaltomaa, Sirpa

AU - Leskinen, Markku

AU - Raitanen, Mika

AU - Kaasinen, Eero

PY - 2016

Y1 - 2016

KW - Bacillus Calmette-Guérin

KW - Epirubicin

KW - Instillation therapy

KW - Interferon ?-2b

KW - Mitomycin C

KW - Recurrent non-muscle-invasive bladder cancer

KW - SWOG

KW - Bacillus Calmette-Guérin

KW - Epirubicin

KW - Instillation therapy

KW - Interferon ?-2b

KW - Mitomycin C

KW - Recurrent non-muscle-invasive bladder cancer

KW - SWOG

U2 - 10.1016/j.eururo.2016.03.034

DO - 10.1016/j.eururo.2016.03.034

M3 - Article

VL - 70

SP - 341

EP - 347

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 2

ER -